Rithim Biologics, Inc.
Publicly observedWoodbine, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Woodbine | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Rithim Biologics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | R8S7GFCEVKB3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Aug 2024Publicly observed
NIH SBIR/STTR award: Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia
USD 768,857.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant15 Aug 2024Publicly observed
NIH SBIR/STTR award: Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia
USD 1,072,629.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.